Latest news
Gold Royalty Swings to Profit, Doubles Revenue in Record First Half as Shares Lag Analyst Targets - finance.biggo.comfinance.biggo.com · Sat, 08 Aug 2026 18:26:38 GMTOR Royalties (TSX:OR) Valuation Puzzle Deserves Fresh Attention - Kalkine MediaKalkine Media · Fri, 07 Aug 2026 12:39:00 GMTLigand Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 21:03:55 GMTOR Royalties Stock Surges 4.39% as Higher Gold Prices and Expanding Royalty Portfolio Strengthen Investor Confidence - kalkine.cakalkine.ca · Thu, 06 Aug 2026 14:36:00 GMTRoyalty Pharma plc 2026: Revenue $674.14M, EPS $0.04— 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 13:11:01 GMTRoyalty Pharma (Nasdaq: RPRX) lifts H1 2026 cash flow and profit - Stock TitanStock Titan · Wed, 05 Aug 2026 13:03:06 GMTRoyalty Pharma reports Q2 2026: Portfolio Receipts $773M, Royalty Receipts up 14% - TradingViewTradingView · Wed, 05 Aug 2026 11:43:03 GMTReturn on assets % of XOMA Royalty Corporation – MUN:US98419J206 - TradingViewTradingView · Tue, 04 Aug 2026 21:17:25 GMT